Expertise in
22
conditions

Dr. Nathaniel Winstead

Gastroenterology
Imc-Gulf Coast Gastroenterology LLC
188 Hospital Dr, Suite 405, 
Fairhope, AL 
 (1901.4 mi)
Expertise in
22
conditions
Imc-Gulf Coast Gastroenterology LLC
188 Hospital Dr, Suite 405, 
Fairhope, AL 
 (1901.4 mi)
OverviewInsuranceLocationsClinical Research

Overview

Nathaniel Winstead is a Gastroenterologist in Fairhope, Alabama. Dr. Winstead is highly rated in 22 conditions, according to our data. His top areas of expertise are Diverticular Disease, Crohn's Disease, Heartburn, Endoscopy, and Colonoscopy.

His clinical research consists of co-authoring 5 peer reviewed articles and participating in 9 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Gastroenterology
Licenses
Internal Medicine in LA
Hospital Affiliations
Mobile Infirmary Medical Center
Thomas Hospital
Languages Spoken
English
Gender
Male

Insurance

Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.

Accepted insurance plans

  •  Blue Cross Blue Shield
  •  UnitedHealthcare
  •  Humana

Locations

IMC-GULF COAST GASTROENTEROLOGY LLC
188 Hospital Dr, Suite 405, Fairhope, AL 36532

Additional Areas of Focus

Dr. Winstead has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease
Enrollment Status: Completed
Publish Date: December 27, 2024
Intervention Type: Drug
Study Drugs: Mirikizumab, Ustekinumab
Study Phase: Phase 3
Evaluation of the ctDNA LUNAR Test in an Average Patient Screening Episode
Evaluation of the ctDNA LUNAR Test in an Average Patient Screening Episode
Enrollment Status: Active_not_recruiting
Publish Date: July 03, 2024
A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
Enrollment Status: Completed
Publish Date: June 21, 2024
Intervention Type: Drug
Study Drug: Ontamalimab
Study Phase: Phase 3
Blood Collection Sub-Study of Exact Sciences Protocol 2019-01: Clinical Validation of an Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, For Colorectal Cancer Screening BLUE-C
Blood Collection Sub-Study of Exact Sciences Protocol 2019-01: Clinical Validation of an Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, For Colorectal Cancer Screening BLUE-C
Enrollment Status: Completed
Publish Date: September 28, 2023
Intervention Type: Other
Clinical Validation of An Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, for Colorectal Cancer Screening BLUE-C
Clinical Validation of An Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, for Colorectal Cancer Screening BLUE-C
Enrollment Status: Completed
Publish Date: September 01, 2023
Intervention Type: Procedure, Diagnostic test
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 307)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 307)
Enrollment Status: Terminated
Publish Date: March 31, 2022
Intervention Type: Drug, Other
Study Drug: Ontamalimab
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 303)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 303)
Enrollment Status: Completed
Publish Date: January 14, 2022
Intervention Type: Other, Drug
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 306)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 306)
Enrollment Status: Terminated
Publish Date: May 11, 2021
Intervention Type: Other, Biological
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 302)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 302)
Enrollment Status: Terminated
Publish Date: April 26, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 8 Less Clinical Trials

5 Total Publications

Medical management of constipation.
Medical management of constipation.
Journal: Clinics in colon and rectal surgery
Published: March 02, 2013
Similar Doctors
Expertise in
47
conditions
Dr. Matthew Eves
Gastroenterology
Expertise in
47
conditions
Dr. Matthew Eves
Gastroenterology

Imc-Gulf Coast Gastroenterology LLC

188 Hospital Dr, Suite 405, 
Fairhope, AL 
251-990-0360
Languages Spoken:
English
See accepted insurances

Matthew Eves is a Gastroenterologist in Fairhope, Alabama. Dr. Eves is highly rated in 47 conditions, according to our data. His top areas of expertise are Choledocholithiasis, Acute Pancreatitis, Pancreatic Cancer, Endoscopy, and Colonoscopy.

Expertise in
38
conditions
Dr. Charles Johnson
Gastroenterology
Expertise in
38
conditions
Dr. Charles Johnson
Gastroenterology

Usa Health Community Providers LLC

6801 Airport Blvd, 
Mobile, AL 
 (21.5 mi)
251-266-3580
Languages Spoken:
English
See accepted insurances

Charles Johnson is a Gastroenterologist in Mobile, Alabama. Dr. Johnson is highly rated in 38 conditions, according to our data. His top areas of expertise are Diverticular Disease, Colitis, Viral Gastroenteritis, Colonoscopy, and Gastrectomy.

Expertise in
35
conditions
Dr. Robert Lerner
Gastroenterology
Expertise in
35
conditions
Dr. Robert Lerner
Gastroenterology

Imc-Diagnostic And Medical Clinic LLC

5 Mobile Infirmary Cir, Suite G805, 
Mobile, AL 
 (16.7 mi)
251-435-6590
Languages Spoken:
English
See accepted insurances

Robert Lerner is a Gastroenterologist in Mobile, Alabama. Dr. Lerner is highly rated in 35 conditions, according to our data. His top areas of expertise are Lower Esophageal Ring, Benign Esophageal Stricture, Diverticular Disease, Endoscopy, and Gastrostomy.

Areas of Expertise

When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

To learn more about how MediFind determines the expertise levels, check out our expert tiers page.

Search for your specific condition
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile